Prof. Dr. Tevfik Fikret Çermik

• Breast Neoplasms 20 publications
  Source: OpenAlex / PubMed MeSHView publications
• Prostatic Neoplasms 13 publications
• Lung Neoplasms 9 publications
• Adenocarcinoma 7 publications
• Bone Neoplasms 5 publications
• Carcinoma 5 publications
• Neuroendocrine Tumors 5 publications
• Stomach Neoplasms 4 publications
• Thyroid Neoplasms 4 publications
• Adrenal Gland Neoplasms 3 publications
• Liver Neoplasms 3 publications
• Pancreatic Neoplasms 3 publications
• Urinary Bladder Neoplasms 3 publications
• Meningeal Neoplasms 3 publications
• Hodgkin Disease 3 publications
• Colorectal Neoplasms 2 publications
• Osteonecrosis 2 publications
• Melanoma 2 publications
• Colonic Neoplasms 2 publications
• Brain Neoplasms 2 publications
• Lymphoma, Non-Hodgkin 2 publications
• Carcinoma, Neuroendocrine 2 publications
• Carcinoma, Papillary 2 publications
• Spinal Cord Injuries 2 publications
• Pulmonary Embolism 2 publications
• Carcinoma, Non-Small-Cell Lung 2 publications
• Kidney Failure, Chronic 2 publications

Medical areas of interest stated by the doctor on the institution profile. Source: acibadem.com.tr.

Experience

• 2024Acıbadem Healthcare Groupacibadem.com.tr
• 2021 - 2023Chair of the Board of Directors, Turkish Society of Nuclear Medicineacibadem.com.tr
• 2017 - 2020University of Health Sciences, Hamidiye Faculty of Medicine / Professor, Head of the Department of Nuclear Medicineacibadem.com.tr
• 2017 - 2024University of Health Sciences, Hamidiye Faculty of Medicine / Professor, Faculty Memberacibadem.com.tr
• 2015 - 2018Associate Editor, Nükleer Tıp Seminerleri (Nuclear Medicine Seminars)acibadem.com.tr
• 2015 - 2017Sakarya University Faculty of Medicine / Professor, Head of the Department of Nuclear Medicineacibadem.com.tr
• 2014 - 2019Editor-in-Chief, İstanbul Medical Journal (İstanbul Tıp Dergisi)acibadem.com.tr
• 2014 - 2021General Secretary of the Board of Directors, Turkish Society of Nuclear Medicineacibadem.com.tr
• 2012 - 2014Associate Editor, İstanbul Medical Journal (İstanbul Tıp Dergisi)acibadem.com.tr
• 2007 - 2024Education and Administrative Lead (Head of Department), Department of Nuclear Medicine, İstanbul Training and Research Hospitalacibadem.com.tr
• 2006 - 2007Trakya University Faculty of Medicine / Associate Professoracibadem.com.tr
• 2001 - 2006Trakya University Faculty of Medicine / Assistant Professoracibadem.com.tr
• 2000 - 2001Trakya University Faculty of Medicine / Specialist Physicianacibadem.com.tr
• 1995 - 2000Trakya University Faculty of Medicine / Residentacibadem.com.tr
• 1993 - 1995Bolu State Hospital / Physicianacibadem.com.tr
• 1992 - 1993Eruh State Hospital, Siirt / Physicianacibadem.com.tr

Education

• 2006European Board Certificate in Nuclear Medicine (FEBNM)acibadem.com.tr
• 2006University of Pennsylvania, Department of Radiology (Nuclear Medicine), Research Fellowacibadem.com.tr
• 2000Trakya University Faculty of Medicine, Nuclear Medicine (specialty training)acibadem.com.tr
• 1992İstanbul University Cerrahpaşa Faculty of Medicine (medical degree)acibadem.com.tr

• SpecialtyNuclear Medicineacibadem.com.trFrom source
• InstitutionAcıbadem Maslak Hastanesiacibadem.com.trFrom source
• Area of workBreast NeoplasmsExtracted from 20 publications · Model version —From source
• Publications200 publicationsOpenAlex, Europe PMCFrom source
• ORCID0000-0001-7622-7277ORCIDFrom source
• Last synchronised4 November 2026 20:45https://www.acibadem.com.tr/doktor/tevfik-fikret-cermik/acibadem.com.tr

1. Dual-tracer Imaging of Chromophobe Renal Cell Carcinoma with [⁹⁹ᵐTC]TC-sestamibi and [⁶⁸GA]GA-DPI-4452

   Nuclear Medicine and Molecular Imaging, 2026

   DOI 10.1007/s13139-026-01086-5 Source: OpenAlex

2. Diagnostic Performance of 68 Ga DOTA-Pentixafor PET/CT in Benign Functional Adrenal Cortical Lesions

   Clinical nuclear medicine, 2026

   DOI 10.1097/rlu.0000000000006405 PMID 41941246 Source: Europe PMC

3. Clinical Value of 68 Ga-DOTA-Bombesin PET/CT Compared With 18 F-FDG PET/CT in the Staging of Breast Cancer

   Clinical nuclear medicine, 2026

   DOI 10.1097/rlu.0000000000006582 PMID 42305081 Open-access full textSource: Europe PMC

4. Comparative Performance of 68Ga-FAPI-04 and 18F-FDG PET/CT in Ovarian Cancer: Focus on Peritoneal Carcinomatosis

   World Journal of Nuclear Medicine, 2026

   DOI 10.1055/s-0046-1819631 PMID 42077575 Open-access full textSource: OpenAlex

5. Diagnostic and prognostic importance of 18F-fluorodeoxyglucose PET/computed tomography in primary extranodal and atypically presenting lymphomas

   Nuclear Medicine Communications, 2026

   DOI 10.1097/mnm.0000000000002096 PMID 41496608 1 citation (OpenAlex) Source: OpenAlex

6. From Metabolism to Molecular Phenotype: Carbonic Anhydrase IX–Targeted [ 68 Ga]Ga-DPI-4452 PET/CT in Renal Cell Carcinoma: A Prospective Multicenter Comparison with [ 18 F]FDG PET/CT

   Journal of Nuclear Medicine, 2026

   DOI 10.2967/jnumed.126.273011 PMID 42754347 1 citation (OpenAlex) Source: OpenAlex

7. One Tracer, Whole Syndrome

   Clinical Nuclear Medicine, 2026

   DOI 10.1097/rlu.0000000000006674 PMID 42779534 Source: OpenAlex

8. Can PSMA-Targeting Radiopharmaceuticals Be Useful for Detecting Brain Metastasis of Various Tumors Using Positron Emission Tomography?

   Cancers, 2025

   DOI 10.3390/cancers17183088 PMID 41008930 2 citations (OpenAlex) Open-access full textSource: OpenAlex

9. 18F-FDG PET/CT Positive and 68Ga-DOTA-Bombesin PET/CT Negative Focus of Benign Apocrine Metaplasia Mimicking Malignancy

   Clinical Nuclear Medicine, 2025

   DOI 10.1097/rlu.0000000000005709 PMID 40025668 Source: OpenAlex

10. Calculation of recovery coefficients for partial volume effect correction in PET/CT imaging using a customized anthropomorphic body phantom

    BioMedical Engineering OnLine, 2025

    DOI 10.1186/s12938-025-01330-7 PMID 39955528 1 citation (OpenAlex) Open-access full textSource: OpenAlex